Cutler Group LP Wave Life Sciences Ltd. Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$5.61 - $12.01 $561 - $1,201	-100 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$6.99 - $9.26 $34,950 - $46,300	-5,000 Reduced 98.04%	100 $0
Q3 2020 Oct 27, 2020	BUY	$8.49 - $19.54 $11,037 - $25,402	1,300 Added 34.21%	5,100 $43,000
Q1 2020 May 07, 2020	SELL	$6.94 - $14.22 $79,116 - $162,108	-11,400 Reduced 75.0%	3,800 $35,000
Q4 2019 Feb 06, 2020	BUY	$7.99 - $37.6 $79,900 - $376,000	10,000 Added 192.31%	15,200 $121,000
Q3 2019 Oct 28, 2019	SELL	$19.17 - $27.4 $47,925 - $68,500	-2,500 Reduced 32.47%	5,200 $106,000
Q2 2019 Aug 09, 2019	BUY	$22.93 - $42.84 $176,561 - $329,868	7,700 New	7,700 $200,000
Q4 2018 Feb 05, 2019	SELL	$37.1 - $50.11 $18,550 - $25,055	-500 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$36.35 - $55.2 $18,175 - $27,600	500 New	500 $25,000

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $840M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.